Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 1998

View Archived Issues

Clinical trial of gene therapy to stimulate angiogenesis in angina patients

Laboratory model of McCune-Albright syndrome developed by researchers at NIH

Company Profile: Bavarian Nordic Research Institute

Company Profile: Praecis

Cell proliferation inhibitors developed at Roche

New antiparasitic agent from Kitasato Institute with a novel mechanism of action

Endothelin antagonists discovered at Ajinomoto

Encouraging phase I/II results reported for TP-10

Genetronics will use SBIR grant to develop transdermal delivery system for calcitonin

Snow Brand Milk Products isolates two new immunosuppressants

Unfavorable phase III results lead to setback in CerAxon development

Procept allocates funds for further development of PRO-2000

Name change announced by BBI Pharmaceuticals

Alza licenses two drug delivery technologies to Alkermes

Northfield Laboratories: Q3 highlights

Hypoxia in solid tumors: a new target for selective tumor therapy

Clinical data supports efficacy of Panretin capsule formulation in AIDS-related KS

Tasosartan international status updated

New antirheumatic agent shown effective in long-term patient studies

Nissan Chem. develops chroman derivatives for cardiac insufficiency

Veldona to be marketed in Ghana

PKC inhibitors for inflammatory, immune, allergic and other disorders described by Otsuka

Pharmacokinetics and pharmacodynamics of IDEC-151 reported at European rhematology meeting

New immunosuppressants from Procept

New beta3-agonist presented by Tokyo Tanabe

New antiasthmatic presented by Pola

Sawai's beta3-agonist shows potential in diabetes Rx

First marketing approval for Novartis transplant drug

Zeneca in-licenses novel superstatin from Shionogi

Tanox Biosystems acquires Dutch biotech company

Sepracor receives U.S. patent protection for single-isomer SSRI